For instance, in diabetes mellitus, where patients are at heightened risk for atherosclerosis, BMECs chronically downregulate HSC-protective factors CXCL12 and Ang-1 due to disrupted epidermal growth factor receptor (EGFR) signaling [103]. This evidence concerns the gene EGFR and atherosclerosis.